Spondyloarthropathy Archives - Page 2 of 15

FDA approves Ocrevus for multiple sclerosis

FDA to Review High-Concentration Biosimilar of Adalimumab

By

November 30, 2020

The FDA has accepted for review the BLA for AVT02 (Alvotech), a proposed biosimilar to adalimumab; AbbVie, with high concentration (100mg/mL) dosage forms.

Rheumatoid Arthritis

Infection Risk During Targeted and Biologic Therapies in Rheumatoid Arthritis and Psoriatic Arthritis

By

Tori Rodriguez, MA, LPC, AHC

November 24, 2020

An overview of the risk for infections during targeted and biologic therapies in rheumatoid arthritis and psoriatic arthritis.

Spondyloarthritis

Secukinumab Associated With Reduced Synovitis in Psoriatic Arthritis

By

Brian Park, PharmD

November 13, 2020

The 52-week double-blind, placebo-controlled ULTIMATE study included 166 adult biologic-naive patients with active psoriatic arthritis.

ACR Convergence 2020

Study Supports Safety, Efficacy of Tofacitinib in the Treatment of Ankylosing Spondylitis

By

Emily Pond

November 12, 2020

Researchers evaluated the safety and efficacy of tofacitinib for the treatment of patients with ankylosing spondylitis.

Spondyloarthritis

Guselkumab Provides Sustained Improvements Through 1 Year in Patients With Active Psoriatic Arthritis

By

Amit Akirov, MD

November 10, 2020

Study authors reported on the 1-year safety and efficacy of guselkumab treatment in patients with active psoriatic arthritis.

Spondyloarthritis

Weight Loss Linked to Reduced Disease Activity in Patients With Psoriatic Arthritis and Obesity

By

Emily Pond

November 10, 2020

Researchers assessed the effects of weight loss on disease activity and cardiovascular risk factors in patients with psoriatic arthritis and obesity.

ACR Convergence 2020

Undiagnosed Axial Spondyloarthritis Prevalent Among Patients With Inflammatory Bowel Disease

By

Amit Akirov, MD

November 8, 2020

Study authors evaluated the prevalence of axial spondyloarthritis in patients with inflammatory bowel disease in secondary care.

ACR Convergence 2020

Gut Microbiome Changes Different in Ankylosing Spondylitis and IBD, Associated With Disease Activity

By

Emily Pond

November 7, 2020

Researchers assessed whether the gut microbiome in ankylosing spondylitis and inflammatory bowel disease was different, and whether it correlated with disease activity.

ACR Convergence 2020

Upadacitinib Effective in Reducing Pain in Patients With Psoriatic Arthritis With Inadequate Response to DMARDs

By

Amit Akirov, MD

November 6, 2020

Study authors compared the effect of upadacitinib vs placebo and adalimumab on pain in patients with active psoriatic arthritis.

Spondyloarthritis

Ixekizumab Superior to Placebo in Self-Reported Functioning and Health in Patients With Axial Spondyloarthritis

By

Amit Akirov, MD

November 4, 2020

Researchers evaluated the effect of ixekizumab on self-reported functioning and health in patients with active nonradiographic axial spondyloarthritis.